tiprankstipranks
Amplia Therapeutics Eyes ASX Listing Expansion
Company Announcements

Amplia Therapeutics Eyes ASX Listing Expansion

Amplia Therapeutics Ltd. (AU:ATX) has released an update.

Amplia Therapeutics Limited has announced a new application for the quotation of securities, seeking to list 77,602,838 ordinary fully paid shares on the ASX under the code ATX. The application, dated May 15, 2024, follows previously announced transactions and adheres to the ASX Listing Rules.

For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskAmplia Therapeutics Announces 2024 AGM Details
TipRanks Australian Auto-Generated NewsdeskAmplia Therapeutics Plans New Security Issue
TipRanks Australian Auto-Generated NewsdeskAmplia Therapeutics Expands Market Presence
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!